others only cover them for diabetes
It has been found that retatrutide, a 39 amino acid peptide, can resist cleavage by dipeptidyl peptidase IV, which is responsible for breaking down GLP-1 and GIP, 271 and it also stimulates GLP-1, GIP and glucagon receptors, which is potentially useful for treating obesity and T2DM
Therefore, drugs with a potent antihyperglycemic effect, independent of the glomerular filtration rate, with a low risk of hypoglycemia, that reduce weight in overweight/obese patients and that provide cardiovascular and renal protection, such as GLP-1 receptor agonists, are needed
It's about creating a steady-state concentration of the medication in your body
Let us partner with you on the journey to better health and wellness
Mounjaro and Zepbound (tirzepatide) work slightly differently, targeting both GLP-1 and GIP receptors for potentially enhanced effects